Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of Molecular Diagnostics : JMD|March 30, 2025
A Comprehensive Guide to Achieving New York State Clinical Laboratory Evaluation Program Approval for Next-Generation Sequencing AssaysPhillip M Galbo, Robert F Klees, Blake Burgher, et al.
Annals of Translational Medicine|February 11, 2021
Immune profiling and immunotherapeutic targets in pancreatic cancerFelicia L Lenzo, Shumei Kato, Sarabjot Pabla, et al.
Oncotarget|September 10, 2019
Development and analytical validation of a next-generation sequencing based microsatellite instability (MSI) assaySarabjot Pabla, Jonathan Andreas, Felicia L Lenzo, et al.
Oncoimmunology|December 8, 2018
PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumabSaby George, Antonios Papanicolau-Sengos, Felicia L Lenzo, et al.
Biomarker Research|July 8, 2021
Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and responseSarabjot Pabla, R J Seager, Erik Van Roey, et al.
Plos One|December 2, 2021
A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumorsJeffrey M Conroy, Sarabjot Pabla, Sean T Glenn, et al.
Oncotarget|December 3, 2016
Robust detection of immune transcripts in FFPE samples using targeted RNA sequencingBenjamin E Paluch, Sean T Glenn, Jeffrey M Conroy, et al.
The Journal of Molecular Diagnostics : JMD|October 25, 2017
Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid TumorsJeffrey M Conroy, Sarabjot Pabla, Sean T Glenn, et al.
BMC Medical Genomics|October 21, 2016
Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencingLei Wei, Antonios Papanicolau-Sengos, Song Liu, et al.
BMC Medical Informatics and Decision Making|January 20, 2019
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencingGrace K Dy, Mary K Nesline, Antonios Papanicolau-Sengos, et al.
Pageof 2